Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Reckitt Benckiser Healthcare (UK) Ltd, 103-105 Bath Road, Slough, Berkshire, SL1 3UH, United Kingdom
Strefen Honey and Lemon.
| Pharmaceutical Form |
|---|
|
Lozenge. A round, pale yellow to brown lozenge with an icon intagliated on both sides of the lozenge. |
Active ingredient flurbiprofen 8.75mg.
Excipient(s) with known effect:
Glucose
Sucrose
Wheat Starch*
Sulphites – sulphur Dioxide (E220)*
d-Limonene**
Linalool**
Citral**
Citronellol**
Farnesol**
Geraniol**
Butylate Hydroxyanisole (E220)**
* present in liquid glucose
** present in Lemon Flavour
For excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Flurbiprofen |
Flurbiprofen is a propionic acid derivative NSAID which acts through inhibition of prostaglandin synthesis. In humans flurbiprofen has potent analgesic, antipyretic and anti-inflammatory properties. |
| List of Excipients |
|---|
|
Macrogol 300 |
A push through strip consisting of 250 microns opaque PVC/PVdC (polyvinyl chloride/polyvinyl di-chloride) blister, heat sealed to hard tempered 20 micron aluminium foil. Blisters are enclosed in a cardboard carton in pack sizes of 2, 4, 6, 8, 10, 12, or 16 lozenges.
Reckitt Benckiser Healthcare (UK) Ltd, 103-105 Bath Road, Slough, Berkshire, SL1 3UH, United Kingdom
PL 00063/0714
19/09/2006
| Drug | Countries | |
|---|---|---|
| STREFEN | Spain, Finland, France, Israel, Lithuania, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
